Colorectal Cancer Clinical Trials

Find Colorectal Cancer Clinical Trials Near You

An Observational Study on Longitudinal Nutritional Status and Body Composition Changes in Head and Neck Cancer, Lung Cancer and Rectal Cancer Patients During Antineoplastic Treatments

Status: Recruiting

Location: See location...

Study Type: Observational

SUMMARY

GALENOS 1 is a prospective observational study designed to explore longitudinal changes in nutritional status and body composition in patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer undergoing standard antineoplastic treatments. The study is the preparatory observational component of the FOR-GALE PREVENTION project, which aims to support the future development of a galenic immunonutrition dietary supplement intended to reduce adverse events and improve treatment compliance

Eligibility

Participation Requirements

Sex: All

Minimum Age: 18

Healthy Volunteers: f

View:

• Written informed consent provided before study procedures

• Male or female participants aged 18 years or older

• Histological or cytological documentation of head and neck squamous cell carcinoma, locally advanced rectal cancer, or lung cancer

• Candidate for standard antineoplastic treatment according to clinical practice

• ECOG Performance Status score less than 2

• Adequate kidney, liver, and bone marrow function

• Ability to adhere to study visits and protocol requirements

Locations

Other Locations

Italy

Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo, Candiolo, Turin 10060

RECRUITING

Candiolo

Contact Information

Primary

Valentina Casalone, MD

valentina.casalone@ircc.it

0119933422

Time Frame

Start Date: 2024-09-23

Estimated Completion Date: 2027-12-30

Participants

Target number of participants: 110

Treatments

Head and Neck Squamous Cell Carcinoma Cohort

Patients with pathologically confirmed head and neck squamous cell carcinoma (oropharynx, oral cavity, hypopharynx, larynx, nasopharynx, or sinus cancer) who are candidates for curative or adjuvant chemoradiotherapy according to standard clinical practice

Locally Advanced Rectal Cancer Cohort

Patients with pathologically confirmed locally advanced rectal cancer who are candidates for neoadjuvant chemoradiotherapy according to standard clinical practice

Lung Cancer Cohort

Patients with pathologically or cytologically confirmed lung cancer who are candidates for curative immunotherapy with or without chemotherapy according to standard clinical practice

Related Therapeutic Areas

Head and Neck Squamous Cell Carcinoma (HNSCC)

Lung Cancer

Colorectal Cancer

Similar Clinical Trials

View All